BION — BB Biotech AG Cashflow Statement
0.000.00%
Last trade - 00:00
- CH₣2.22bn
- -CH₣111.79m
- CH₣0.53m
- 64
- 34
- 62
- 53
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Changes in Working Capital | -45.6 | -46.7 | -59.5 | -44.3 | -35.3 |
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 215 | 262 | -94.8 | 231 | 218 |
Financing Cash Flow Items | -1.24 | -0.883 | -0.986 | -1.73 | -5.8 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -205 | -284 | 91.8 | -233 | -220 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 8.63 | -23.9 | -3.98 | -0.887 | -1.45 |